These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32304771)

  • 21. TMEM16A exacerbates renal injury by activating P38/JNK signaling pathway to promote podocyte apoptosis in diabetic nephropathy mice.
    Lian H; Cheng Y; Wu X
    Biochem Biophys Res Commun; 2017 May; 487(2):201-208. PubMed ID: 28392397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
    He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
    J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
    Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
    Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MiR-34a alleviates podocyte injury in mice with diabetic nephropathy by targeted downregulation of Notch signaling pathway].
    Wang H; Liu H; Zhang Y; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1839-1845. PubMed ID: 36651252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cathepsin C is a novel mediator of podocyte and renal injury induced by hyperglycemia.
    Audzeyenka I; Rachubik P; Rogacka D; Typiak M; Kulesza T; Angielski S; Rychłowski M; Wysocka M; Gruba N; Lesner A; Saleem MA; Piwkowska A
    Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118723. PubMed ID: 32302668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
    Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
    Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin attenuates high glucose-induced podocyte apoptosis by regulating functional connections between caveolin-1 phosphorylation and ROS.
    Sun LN; Liu XC; Chen XJ; Guan GJ; Liu G
    Acta Pharmacol Sin; 2016 May; 37(5):645-55. PubMed ID: 26838071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    Gao Y; Ma Y; Xie D; Jiang H
    Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High glucose provokes microvesicles generation from glomerular podocytes via NOX4/ROS pathway.
    Li M; Zhang T; Wu X; Chen Y; Sun L
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31664454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Arrestin 1/2 Aggravates Podocyte Apoptosis of Diabetic Nephropathy via Wnt/β-Catenin Pathway.
    Wang Y; Li H; Song SP
    Med Sci Monit; 2018 Mar; 24():1724-1732. PubMed ID: 29572435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Baoshenfang Formula on Podocyte Injury via Inhibiting the NOX-4/ROS/p38 Pathway in Diabetic Nephropathy.
    Cui FQ; Tang L; Gao YB; Wang YF; Meng Y; Shen C; Shen ZL; Liu ZQ; Zhao WJ; Liu WJ
    J Diabetes Res; 2019; 2019():2981705. PubMed ID: 31179339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
    Huang F; Sheng XX; Zhang HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
    Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
    Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGF receptor deletion in podocytes attenuates diabetic nephropathy.
    Chen J; Chen JK; Harris RC
    J Am Soc Nephrol; 2015 May; 26(5):1115-25. PubMed ID: 25185988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of klotho on the expression of SRGAP2a in podocytes in diabetic nephropathy.
    Jin D; Jia M; Xie Y; Lin L; Qiu H; Lu G
    BMC Nephrol; 2022 Apr; 23(1):151. PubMed ID: 35436879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
    Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
    Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
    Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
    Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAGI2 ameliorates podocyte apoptosis of diabetic kidney disease through communication with TGF-β-Smad3/nephrin pathway.
    Wang T; Li C; Wang X; Liu F
    FASEB J; 2023 Dec; 37(12):e23305. PubMed ID: 37950637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.